Gastric cancer: Biomarkers identified to predict the risk of relapse: Surgical removal of the tumour is considered the basis for curing gastric cancer. However, 40 per cent of patients who have undergone surgery suffer a relapse within two years. A research team led by MedUni Vienna has now investigated a prognostic marker that can be […]
Read More… from Gastric cancer: Biomarkers identified to predict the risk of relapse
Therapy trial for DCIS breast cancer: Women with an early form of breast cancer are more likely to stay free of the disease after an extra radiotherapy boost, new research shows. In the first trial of its kind, experts followed 1,608 women with higher risk ductal carcinoma in situ (DCIS) from 136 participating centres in […]
Scientists discover way to stop spread of devastating childhood cancer: Researchers at the University of East Anglia and University of Manchester have made an important breakthrough that could lead to ‘kinder’ treatments for children with bone cancer, and save lives. Current treatment is gruelling, with outdated chemotherapy cocktails and limb amputation. But despite all of […]
Read More… from Stopping the spread of childhood bone cancer
Babies with brain tumours could benefit from targeted treatment – Tumours in infants biologically distinct from older patients – – Study finds genetic vulnerabilities to existing targeted drugs – – Clinical trials to offer hope for families of youngest patients – Brain cancer in infants is biologically distinct from other childhood brain tumours and could […]
Read More… from Infant brain tumours could benefit from targeted treatment
‘- Aggressive stomach and gullet cancers evolve escape routes under selective pressure from immune system – Findings underline importance of cancer evolution, and could help optimise immunotherapy Aggressive, highly mutated cancers evolve escape routes in response to immune attacks in an ‘evolutionary arms race’ between cancer and the immune system, a new study reports. Gullet […]
Read More… from Cancers Engaged in Evolutionary Arms Race with Immune System
Scientists have unveiled clues about a mysterious molecule called Yin Yang1 – and revealed it may fuel tumour growth in breast cancer. The findings, by a group of international scientists led by Imperial College London, may open avenues for new treatments, and help understand why some tumours become resistant to chemotherapy. Crucially, the findings also […]
An allergy antibody known as Immunoglobulin E, or IgE, may protect the skin against cancer, according to new study led by scientists at Imperial College, London. IgE is a component of the immune system that triggers allergic reactions. The research highlights previously unknown skin defences – and could open avenues for developing new skin cancer […]
Read More… from Allergy antibody may protect skin against cancer
Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tell in advance which treatments will work, a major new study reports. The exciting new technique involves growing ‘mini tumours’ from biopsy samples – and could help end reliance on trial and error in selecting cancer treatments for patients where genetic tests […]
Around 70 per cent of breast cancers are so-called ER positive, which means the cancer cells contain a receptor for the hormone oestrogen. It is this hormone that fuels the tumours. Patients with this type of cancer are offered one of two drugs after surgery to prevent the cancer coming back. One of these drugs, […]
Read More… from Why do some breast cancer drugs stop working?
On Monday 18th April 2016 the parlous lack of funding for research into brain tumours was the subject of a formal parliamentary debate in the House of Commons. The debate comes after years of lobbying by our partner, charity Brain Tumour Research, culminating in a Government e-petition which gained over 120,000 signatures and the publishing of […]
Read More… from Brain tumours come under the spotlight of parliament